Pretomanid: all 33 studies that test it
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TBRecruitingNCT07672405Phase 2
- A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant TuberculosisNot yet recruitingNCT07126639Not applicable
- Program for Rifampicin-Resistant Disease With Stratified Medicine for TuberculosisRecruitingNCT06441006Phase 2/3
- Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisRecruitingNCT06192160Phase 2
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBRecruitingNCT06114628Phase 2
- PanACEA - STEP2C -01RecruitingNCT05807399Phase 2
- Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary TuberculosisActive, not recruitingNCT06058299Phase 2Results posted
- Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of PretomanidCompletedNCT04309656Phase 1Results posted
- A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary TuberculosisCompletedNCT04179500Phase 2Results posted
- Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal FunctionCompletedNCT03896750Phase 1Results posted
- Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult PatientsCompletedNCT03338621Phase 2/3Results posted
- Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant TuberculosisCompletedNCT03086486Phase 3Results posted
- Pretomanid in Adults With Hepatic ImpairmentTerminatedNCT02422524Phase 1Results posted
- Shortening Treatment by Advancing Novel DrugsCompletedNCT02342886Phase 3Results posted
- A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TBCompletedNCT02333799Phase 3Results posted
- Assessing PA-824 for Tuberculosis (the APT Trial)CompletedNCT02256696Phase 2Results posted
- A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.CompletedNCT02193776Phase 2Results posted
- Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)CompletedNCT01691534Phase 2Results posted
- Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)CompletedNCT01498419Phase 2Results posted
- Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)CompletedNCT01215851Phase 2Results posted
- Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)CompletedNCT00944021Phase 2Results posted
- PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary TuberculosisCompletedNCT00567840Phase 2Results posted
- A Pan-TB Regimen Targeting Host and MicrobeActive, not recruitingNCT05686356Phase 2/3
- Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant TuberculosisCompletedNCT05586230Phase 1
- Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in IndiaActive, not recruitingNCT05040126Phase 3
- Economic Evaluation of New MDR TB RegimensCompletedNCT04207112Phase 2/3
- A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects.CompletedNCT03202693Phase 1
- Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)CompletedNCT02589782Phase 2/3
- Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-009)CompletedNCT01830439Phase 1
- Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult SubjectsCompletedNCT01828827Phase 1
- Evaluation of the Pharmacokinetic Interaction Between PA-824 and MidazolamCompletedNCT01768273Phase 1
- Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy VolunteersCompletedNCT01674218Phase 1
- Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or RifampinCompletedNCT01571414Phase 1